GM1bCer (d18:1/8:0) is a sialic-acid-containing glycosphingolipid that can be used as a useful standard in the research of genetic glycolipids for cancer therapeutics.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.